Literature DB >> 1521320

Developmental changes in brain kynurenic acid concentrations.

M F Beal1, K J Swartz, O Isacson.   

Abstract

The cerebral distribution and regulation of excitatory amino acid levels may play a crucial role in neuronal development. In the present study we examined concentrations of the endogenous excitatory amino acid antagonist kynurenic acid and related substances during development in fetal and neonatal rat brain and fetal non-human primate cerebral cortex. Kynurenic acid concentrations in rat fetal whole brain were significantly increased 4-5 fold prenatally, then declined rapidly at 1 day after birth, and reached adult concentrations at 7 days after birth. L-Kynurenine concentrations were also markedly increased prior to birth and then declined to adult concentrations at 1 day after birth. L-Tryptophan was increased 3 fold before birth, and decreased to adult concentrations 1 day after birth. In contrast concentrations of dopamine, norepinephrine, 3,4-dihydroxyphenylacetic acid and homovanillic acid increased 1 day prior to birth and continued to increase following birth. Fetal baboon cerebral cortex showed significant increases in kynurenic acid concentrations both pre-term and near-term as compared with adult concentrations. These results show that marked changes in kynurenic acid concentrations occur prior to and following birth. It is possible that high levels of kynurenic acid prior to birth inhibit neurite branching and development of excitatory synapses, which then develop rapidly in parallel with the decrease in kynurenic acid levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521320     DOI: 10.1016/0165-3806(92)90256-v

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  17 in total

1.  Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.

Authors:  Francesca M Notarangelo; Sarah Beggiato; Robert Schwarcz
Journal:  Dev Neurosci       Date:  2019-05-22       Impact factor: 2.984

Review 2.  The kynurenine pathway and the brain: Challenges, controversies and promises.

Authors:  Robert Schwarcz; Trevor W Stone
Journal:  Neuropharmacology       Date:  2016-08-07       Impact factor: 5.250

3.  Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development.

Authors:  G Cannazza; A Chiarugi; C Parenti; P Zanoli; M Baraldi
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

Review 4.  Lysine metabolism in mammalian brain: an update on the importance of recent discoveries.

Authors:  André Hallen; Joanne F Jamie; Arthur J L Cooper
Journal:  Amino Acids       Date:  2013-09-17       Impact factor: 3.520

Review 5.  α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.

Authors:  Arthur J L Cooper; Tomiko Kuhara
Journal:  Metab Brain Dis       Date:  2013-11-14       Impact factor: 3.584

Review 6.  Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

Authors:  Francesca M Notarangelo; Ana Pocivavsek
Journal:  Neuropharmacology       Date:  2016-03-02       Impact factor: 5.250

7.  Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats.

Authors:  Ana Pocivavsek; Marian A R Thomas; Greg I Elmer; John P Bruno; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2014-03-04       Impact factor: 4.530

Review 8.  Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Authors:  Dániel Sandi; Zsanett Fricska-Nagy; Krisztina Bencsik; László Vécsei
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

9.  Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

Authors:  R Kaddurah-Daouk; S H Boyle; W Matson; S Sharma; S Matson; H Zhu; M B Bogdanov; E Churchill; R R Krishnan; A J Rush; E Pickering; M Delnomdedieu
Journal:  Transl Psychiatry       Date:  2011       Impact factor: 6.222

10.  A single prenatal lipopolysaccharide injection has acute, but not long-lasting, effects on cerebral kynurenine pathway metabolism in mice.

Authors:  Francesca M Notarangelo; Robert Schwarcz
Journal:  Eur J Neurosci       Date:  2021-08-17       Impact factor: 3.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.